Neurology

Top Medical News
an hour ago
There appears to be substantial long-term risks and consequences of anticoagulant-related major bleeding in patients with a first unprovoked venous thromboembolism (VTE), suggests a recent study.
2 days ago
Individuals with types 1 (T1D) and 2 diabetes (T2D) mellitus who adhere to a Mediterranean dietary pattern are at lower risk of cardiovascular disease (CVD) and microvascular complications, including diabetic retinopathy and nephropathy, a study has found.
Stephen Padilla, 3 days ago
A recent systematic review and meta-analysis has revealed that about one in three adults with cerebral palsy are hypertensive, which stresses the importance of clinical screening for blood pressure (BP) in these individuals beginning in young adulthood.
5 days ago
A healthy diet, defined by adherence to either the Mediterranean diet, the World Health Organization (WHO) guidelines, or Dutch Health Council dietary guidelines, is predictive of better cognitive function and slower cognitive decline with ageing from middle age onward, a study has shown.
Tristan Manalac, 5 days ago
Wearable inertial sensors can detect gait disturbances with high sensitivity even during the early stages of multiple sclerosis (MS), where established clinical global scales may miss slight deviations in gait, according to a recent study.
5 days ago
In the treatment of children with epilepsy, oxcarbazepine (OXC), but not levetiracetam (LEV), appears to contribute to a higher risk of fragility fracture, a study has found.
Roshini Claire Anthony, 5 days ago

Swapping regular salt for a reduced-sodium salt substitute may cut stroke, major adverse cardiovascular event (MACE)*, and death rates in individuals with a risk of stroke, according to results of the SSaSS** trial.

Special Reports
04 May 2018
Multiple sclerosis (MS) is one of the most common neurological disorders – affecting over 2.3 million people globally – and it is the leading cause of nontraumatic disability in young adults. However,the availability of supportive resources and services for people with MS is scarce in many regions of the world. In Malaysia, the prevalence of MS is estimated at 2-3/100,000; the current Malaysian clinical practice guidelines on the management of MS recommend disease modifying agents, such as interferon-β and teriflunomide, as first-line therapeutic agents. In this article, Dr Singer - in partnership with Sanofi and the Malaysian Society of Neurosciences - shares his insights into managing MS dynamically, highlighting the importance of early intervention in improving patient outcomes.
Roshini Claire Anthony, 22 Nov 2016

Blood pressure lowering medications and statins do not prevent cognitive and functional decline in elderly patients, according to results of the HOPE-3 trial* presented at the Scientific Sessions of the American Heart Association (AHA 2016) held recently in New Orleans, Louisiana, US.

Dr. Rose Zhao-Wei Ting, 16 Nov 2016
A 55-year-old man presented with almost one year history of heat intolerance, mild palpitation and significant weight loss. Free T3 and T4 were elevated with normal TSH. Patient had suboptimal response to carbimazole therapy.
Conference Reports
Roshini Claire Anthony, 27 Aug 2021

Several studies presented at AAIC 2021 have suggested a possible link between COVID-19 and cognitive impairment.

Elaine Soliven, 25 Aug 2021
Treatment with high-dose aducanumab shows less clinical decline across individual items or domains of cognition, function, and behaviour compared with placebo in patients with early symptomatic Alzheimer’s disease (AD), according to the EMERGE* study presented at AAIC 2021.
Roshini Claire Anthony, 23 Aug 2021

Transgender adults had a higher likelihood of experiencing subjective cognitive decline (SCD) and SCD-related functional limitations compared with their cisgender counterparts, according to a study presented at AAIC 2021.

Elaine Soliven, 19 Aug 2021
Midlife adults aged between 50 and 70 years who reported a short sleep duration of ≤6 hours/night had an increased risk of developing dementia later in life, according to a study presented at AAIC 2021.
Audrey Abella, 18 Aug 2021
Two studies presented at AAIC 2021 showed a potential neuroprotective effect of a ketogenic supplement or diet: In one study, consumption of a keto drink was associated with improvements in dorsal attention network (DAN) functional connectivity in mild cognitive impairment (MCI). Another study showed the keto diet’s potential to improve aberrant default mode network (DMN) connectivity patterns in adults at risk for Alzheimer’s disease (AD).
Pearl Toh, 14 Aug 2021
Improved air quality was associated with a slower cognitive decline and a lower risk of developing dementia, according to studies presented at AAIC 2021.
Roshini Claire Anthony, 13 Aug 2021

A new systematic review and meta-analysis presented at AAIC 2021 has hinted at a high prevalence of young-onset dementia (YOD) worldwide.